world1 outlet covering thisCalibrating

Erasca plans $500 million stock offering to fund drug research

First publishedJul 13, 20:28 UTC

Last updatedJul 14, 00:33 UTC · 16m ago

1 outlets over time — hover a bar for its window & outletslast updated

Erasca plans $500 million stock offering to fund drug research

● Story signals

How strong is this topic?

5.5/10Significanceimpact & urgency

5.0/10Source trustoutlet authority

1Outletsindependent sources

Significance weighs impact, urgency & coverage breadth · Source trust is the outlets' average authority · more outlets means a more confirmed story.

Answer

Erasca plans $500 million stock offering to fund drug research.

Reported by 1 outlet — Investing.com · Company News. See all sources ↓

Why it matters

A world story we're tracking; its significance and source trust firm up as more outlets confirm it.

In brief

What's the story?: Erasca plans $500 million stock offering to fund drug research.
How widely is it covered?: 1 outlet, average source rating 5.0/10.
When was it last updated?: 16m ago.

Different angles across outlets

Coverage map

How outlets are framing the same story

Here's how each outlet is covering the story — compare their headlines and timing at a glance.

Coverage card1 outlet
1Coverage
Scouting report
Erasca plans $500 million stock offering to fund drug research
Sources1
TypeCoverage
Investing.com · Company NewsJul 13, 20:28

Related in the knowledge graph

organizationErasca

Sources (1)

Avg source rating 5.0/10

Investing.com · Company News5

Share this article

X / Twitter LinkedIn WhatsApp

Summarize with AI (opens AI chat with article URL · Gemini: prompt copied to clipboard)

GPT Perplexity Gemini Claude